Health In Tech, Inc. (HIT) 10-Year Financial Performance & Capital Metrics

HIT • • Industrial / General

TechnologyApplication SoftwareFinancial Technology & PaymentsDigital Banking Platforms

AboutHealth In Tech, Inc. operates as an insurance technology platform company. The company offers reference-based pricing, group insurance captives, community health plans, and association health programs for small businesses; and enhance do it yourself benefit system (eDIYBS), a web-based SaaS quoting platform to quote health insurance for small to medium sized employers. It also provides health intelligence (HI) card to streamline the management of medical records and claims; and HI performance network, which offers a series of hospital facilities, as well as delivers medicare-based reimbursement pricing. Health In Tech, Inc. was founded in 2014 and is headquartered in Stuart, Florida.Show more

Revenue $19M +1.8%
EBITDA $2M -58.9%
Net Income $670K -72.9%
EPS (Diluted) 0.01 -73.1%
Gross Margin 79.21% -10.0%
EBITDA Margin 7.86% -59.6%
Operating Margin 5.08% -71.2%
Net Margin 3.44% -73.4%
ROE 6.96% -89.4%
ROIC 13.35% -84.6%
Debt/Equity 0.02 -95.0%
Interest Coverage 2.00 -99.9%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Company is almost debt free
✓Excellent 3Y average ROE of 26.2%
✓High quality earnings: Operating CF exceeds net income
✓Efficient asset utilization: 1.2x turnover

✗Weaknesses

✗Trading more than 30% below 52-week high

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y-

3Y-

TTM55.15%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM-20.9%

EPS CAGR

10Y-

5Y-

3Y-

TTM-22.81%

ROCE

10Y Avg24.78%

5Y Avg24.78%

3Y Avg24.78%

Latest9.72%

Peer Comparison

Digital Banking Platforms

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
GWREGuidewire Software, Inc.	14.12B	166.09	205.05	22.64%	7.23%	6%	2.09%	0.49
DAVEDave Inc.	2.34B	192.06	45.84	33.96%	29.87%	50.37%	5.33%	0.41
INTUIntuit Inc.	154.33B	554.58	40.57	15.63%	21.19%	21.31%	3.94%	0.34
CCBCoastal Financial Corporation	1.72B	113.69	34.98	30.92%	7.84%	10.04%	14.54%	0.12
SPNSSapiens International Corporation N.V.	2.43B	43.45	33.68	5.4%	11.4%	12.2%	2.97%	0.13
SSNCSS&C Technologies Holdings, Inc.	21B	86.05	28.68	6.89%	13.86%	12.2%	6.32%	1.09
TBBKThe Bancorp, Inc.	3.09B	70.39	16.41	16.11%	30.63%	29.28%	7.2%	0.16
CWANClearwater Analytics Holdings, Inc.	6.98B	24.19	14.40	22.72%	61.25%	19.6%	0.99%	0.07

Profit & Loss

	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	5.77M	19.15M	19.49M
Revenue Growth %	-	2.32%	0.02%
Cost of Goods Sold+	334.19K	2.3M	4.05M
COGS % of Revenue	0.06%	0.12%	0.21%
Gross Profit+	5.44M	16.85M	15.44M
Gross Margin %	0.94%	0.88%	0.79%
Gross Profit Growth %	-	2.1%	-0.08%
Operating Expenses+	5.23M	13.46M	14.45M
OpEx % of Revenue	0.91%	0.7%	0.74%
Selling, General & Admin	4.44M	11.46M	11.64M
SG&A % of Revenue	0.77%	0.6%	0.6%
Research & Development	794.62K	2M	2.81M
R&D % of Revenue	0.14%	0.1%	0.14%
Other Operating Expenses	0	0	0
Operating Income+	205.58K	3.38M	989.9K
Operating Margin %	0.04%	0.18%	0.05%
Operating Income Growth %	-	15.46%	-0.71%
EBITDA+	205.58K	3.72M	1.53M
EBITDA Margin %	0.04%	0.19%	0.08%
EBITDA Growth %	-	17.11%	-0.59%
D&A (Non-Cash Add-back)	0	339.3K	541.14K
EBIT	205.58K	3.42M	1.38M
Net Interest Income+	-4.57K	38.8K	-372.12K
Interest Income	0	40.86K	122.89K
Interest Expense	4.57K	2.05K	495K
Other Income/Expense	-4.57K	38.8K	-100.9K
Pretax Income+	201.01K	3.42M	889K
Pretax Margin %	0.03%	0.18%	0.05%
Income Tax+	121.27K	945.24K	218.52K
Effective Tax Rate %	0.4%	0.72%	0.75%
Net Income+	79.74K	2.48M	670.48K
Net Margin %	0.01%	0.13%	0.03%
Net Income Growth %	-	30.06%	-0.73%
Net Income (Continuing)	79.74K	2.48M	670.48K
Discontinued Operations	0	0	0
Minority Interest	367.77K	0	0
EPS (Diluted)+	0.00	0.05	0.01
EPS Growth %	-	-	-0.73%
EPS (Basic)	0.00	0.05	0.01
Diluted Shares Outstanding	54.07M	54.07M	53.66M
Basic Shares Outstanding	54.07M	54.07M	67.05M
Dividend Payout Ratio	-	-	-

Balance Sheet

	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	25.43M	6.86M	10.78M
Cash & Short-Term Investments	1.49M	2.42M	7.85M
Cash Only	1.49M	2.42M	7.85M
Short-Term Investments	0	0	0
Accounts Receivable	976.86K	3.92M	2.15M
Days Sales Outstanding	61.8	74.65	40.21
Inventory	0	0	0
Days Inventory Outstanding	-	-	-
Other Current Assets	22.96M	526.15K	787.16K
Total Non-Current Assets+	3.13M	4.64M	4.98M
Property, Plant & Equipment	321.81K	266.64K	206.27K
Fixed Asset Turnover	17.93x	71.83x	94.49x
Goodwill	0	0	0
Intangible Assets	2.76M	3.56M	3.96M
Long-Term Investments	0	0	0
Other Non-Current Assets	48.23K	816K	816K
Total Assets+	28.56M	11.5M	15.77M
Asset Turnover	0.20x	1.66x	1.24x
Asset Growth %	-	-0.6%	0.37%
Total Current Liabilities+	24.02M	4.78M	2.13M
Accounts Payable	474.39K	2.62M	1.86M
Days Payables Outstanding	518.13	415.23	167.47
Short-Term Debt	0	1.65M	0
Deferred Revenue (Current)	0	0	0
Other Current Liabilities	23.37M	0	0
Current Ratio	1.06x	1.43x	5.06x
Quick Ratio	1.06x	1.43x	5.06x
Cash Conversion Cycle	-	-	-
Total Non-Current Liabilities+	3.12M	628.67K	468.49K
Long-Term Debt	0	0	0
Capital Lease Obligations	265.37K	206.69K	139.81K
Deferred Tax Liabilities	288K	421.98K	328.68K
Other Non-Current Liabilities	2.57M	0	0
Total Liabilities	27.14M	5.41M	2.6M
Total Debt+	316.09K	1.92M	206.69K
Net Debt	-1.17M	-501.18K	-7.64M
Debt / Equity	0.22x	0.31x	0.02x
Debt / EBITDA	1.54x	0.51x	0.14x
Net Debt / EBITDA	-5.70x	-0.13x	-4.99x
Interest Coverage	44.97x	1648.68x	2.00x
Total Equity+	1.42M	6.09M	13.17M
Equity Growth %	-	3.3%	1.16%
Book Value per Share	0.03	0.11	0.25
Total Shareholders' Equity	1.05M	6.09M	13.17M
Common Stock	45K	51.77K	54.62K
Retained Earnings	794.26K	3.27M	3.94M
Treasury Stock	0	0	0
Accumulated OCI	0	0	0
Minority Interest	367.77K	0	0

Cash Flow

	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	782.75K	1.53M	2.18M
Operating CF Margin %	0.14%	0.08%	0.11%
Operating CF Growth %	-	0.95%	0.42%
Net Income	-243.34K	3.96M	670.48K
Depreciation & Amortization	0	339.3K	541.14K
Stock-Based Compensation	566.04K	0	468.49K
Deferred Taxes	9K	133.98K	-93.3K
Other Non-Cash Items	0	-16K	432.88K
Working Capital Changes	451.06K	-2.89M	156.52K
Change in Receivables	-716K	-2.94M	1.77M
Change in Inventory	0	0	0
Change in Payables	449.95K	2.15M	-851.96K
Cash from Investing+	-1.22M	-1.94M	-836.75K
Capital Expenditures	-1.22M	-1.14M	-900.75K
CapEx % of Revenue	0.21%	0.06%	0.05%
Acquisitions	-	-	-
Investments	-	-	-
Other Investing	0	-800K	64K
Cash from Financing+	1.88M	1.34M	4.09M
Debt Issued (Net)	-	-	-
Equity Issued (Net)	-	-	-
Dividends Paid	0	0	0
Share Repurchases	-	-	-
Other Financing	-46.97K	-306.12K	-1.98M
Net Change in Cash	-	-	-
Free Cash Flow+	-436.63K	384.52K	1.28M
FCF Margin %	-0.08%	0.02%	0.07%
FCF Growth %	-	1.88%	2.32%
FCF per Share	-0.01	0.01	0.02
FCF Conversion (FCF/Net Income)	9.82x	0.62x	3.25x
Interest Paid	4.57K	2.05K	0
Taxes Paid	0	479.21K	558.52K

Key Ratios

Metric	2022	2023	2024
Return on Equity (ROE)	5.62%	65.94%	6.96%
Return on Invested Capital (ROIC)	62.57%	86.92%	13.35%
Gross Margin	94.21%	87.97%	79.21%
Net Margin	1.38%	12.93%	3.44%
Debt / Equity	0.22x	0.31x	0.02x
Interest Coverage	44.97x	1648.68x	2.00x
FCF Conversion	9.82x	0.62x	3.25x
Revenue Growth	-	231.93%	1.77%

Frequently Asked Questions

Valuation & Price

Health In Tech, Inc. (HIT) has a price-to-earnings (P/E) ratio of 113.8x. This suggests investors expect higher future growth.

Growth & Financials

Health In Tech, Inc. (HIT) reported $30.7M in revenue for fiscal year 2024. This represents a 432% increase from $5.8M in 2022.

Health In Tech, Inc. (HIT) grew revenue by 1.8% over the past year. Growth has been modest.

Yes, Health In Tech, Inc. (HIT) is profitable, generating $1.4M in net income for fiscal year 2024 (3.4% net margin).

Dividend & Returns

Health In Tech, Inc. (HIT) has a return on equity (ROE) of 7.0%. This is below average, suggesting room for improvement.

Health In Tech, Inc. (HIT) generated $1.5M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

← Back to Screener